Skip to main content
MATX $217.30 +1.66%
MATX logo

MATX · Matson, Inc.

Track MATX — free
$217.30 +3.54 (+1.66%) At close · Aug 14
Market Cap
$6.41B
Shares
29.90M
All earnings calls

Earnings call · FY2025 Q2

Matson, Inc. Q2 FY2025 Earnings Call

Matson, Inc. Q2 FY2025 Earnings Call

Concluded Jul 31, 2025 Audio replay
Jul 31, 2025 36:00 31 turns
Period
FY2025 Q2
Runtime
36:00
Sources
4 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

China service volumes and tariffs 28 Hawaii trade lane 13 Logistics segment 12 Transshipment and Vietnam expansion 12 Guam trade lane 9 Alaska trade lane 6

Management tone

Positive

Net tone +25 · moderate hedging

Grounding quotes
  • “our second quarter financial performance exceeded our expectations amid the challenges of market uncertainty and volatility arising from tariffs and global trade”
  • “given our financial performance in the second quarter, and assuming these factors do not materially change from current conditions, we are raising our outlook for the full year 2025”
  • “we expect lower year-over-year freight rates and volume compared to the elevated demand levels achieved in the third quarter last year and our expectation of a muted peak season this year”
  • “it is encouraging for us to see how well we've held up in a very dislocated market”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $830.50M -2% YoY
Diluted EPS $2.92 -11.8% YoY
Net income $94.70M -16.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · segments

Ocean Transportation Segment$675.60M -2.1% YoY
Logistics Services Segment$154.90M -1.7% YoY

Capital returned

Buybacks · derived
$93.50M
Shares repurchased
900,000
Dividend / share
$0.36
Full-screen source Call document